Taraboletti, Giulia <br/><br/>
Potential antagonism of tubulin-binding anticancer agents in combination therapies.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2005 
 - 2720-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-1616  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Adhesion--drug effects<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cisplatin--administration & dosage<br/>Colchicine--administration & dosage<br/>Cytoskeleton--drug effects<br/>Docetaxel<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--administration & dosage<br/>Drug Interactions<br/>Endothelial Cells--drug effects<br/>Female<br/>Humans<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Microscopy, Fluorescence<br/>Necrosis--prevention & control<br/>Organophosphorus Compounds--administration & dosage<br/>Paclitaxel--administration & dosage<br/>Protein Binding<br/>Taxoids--administration & dosage<br/>Tubulin--metabolism<br/>Umbilical Veins--cytology<br/>Vincristine--administration & dosage<br/>Xenograft Model Antitumor Assays--methods